ArticleThe Journal of investigative dermatology2009

Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy.

Christoph M Lanschuetzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.